Gatifloxacin
Back to searchMolecule Structure
Scientific Name
Gatifloxacin
Description of the Drug
Gatifloxacin is a fourth generation fluoroquinolone used to treat a wide variety of infections in the body.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01044
http://www.drugbank.ca/drugs/DB01044
Brand Name(s)
Gatifloxacin, Tequin, Zymar, Zymaxid
Company Owner(s)
Apotex Inc, Bristol Myers Squibb, Sandoz Inc, Allergan, Bristol Myers Squibb Co Pharmaceutical Research Institute, Allergan Inc, Akorn Operating Co Llc, Torrent Pharmaceuticals Ltd, Lupin Ltd, Rising Pharma Holdings Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Topoisomerase IV | PROTEIN COMPLEX | INHIBITOR | CHEMBL2363033 |
DNA gyrase | PROTEIN COMPLEX | INHIBITOR | CHEMBL2311225 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL22591 | |||
PharmGKB | PA449738 | |||
Human Metabolome Database | HMDB0015178 | |||
DrugBank | DB01044 | |||
PubChem: Thomson Pharma | 14755600 | |||
PubChem | 5379 | 4872633 | ||
Mcule | MCULE-4557972261 | |||
NMRShiftDB | 80004384 | |||
LINCS | LSM-5139 | |||
Nikkaji | J523.172H | |||
BindingDB | 50117914 | |||
EPA CompTox Dashboard | DTXSID5045704 | |||
DrugCentral | 1280 | |||
Brenda | 253090 | |||
ChemicalBook | CB2726045 | |||
Guide to Pharmacology | 10816 | |||
rxnorm | GATIFLOXACIN | ZYMAR | GATIFLOXACIN ANHYDROUS | ZYMAXID |
PubChem: Drugs of the Future | 12014137 | |||
KEGG Ligand | C07661 | |||
ChEBI | 5280 |